The synthetic disaccharide 3-0-a-tyvelopyranosyl-a-D-mannopyranoside, identical to the 0 antigen 9 determinant in Salmonella, covalently linked to bovine serum albumin and suspended in Freund complete adjuvant, was In Salmonella there has accumulated evidence that the qualitative constitution of the lipopolysaccharide (a component of the outer membrane containing the 0 antigen of the bacteria) is of importance for virulence (12, 13) . Killed vaccines of bacteria afford specific protection against infection by organisms of homologous 0-antigenic type but not against organisms of heterologous type (12, 13). The structure of the polysaccharide part of the lipopolysaccharide with the 0-antigenic specificity has been stablished for several Salmonella species (6). If key 0-antigenic determinants, without endotoxic activity, can be coupled to immunogenic carriers, it might be possible to give protection from infection by many organisms for which no effective prophylaxis is now available. Previous investigations have shown that individual dideoxyhexoses of Salmonella were haptenes which functioned as antigenic determinants when coupled to bovine serum albumin (BSA) or egg albumin and injected into goats and rabbits (18, 19) . The potential use of these synthetic antigens for eliciting protection was not studied.
Parenteral vaccines against enteric bacterial infections are not satisfactory: the vaccines are lacking in efficacy, the immunity they confer is inadequate, and they tend to cause side reactions (22) . The vaccines are composed of whole bacteria killed by one or another method. The poor effect and the side reactions are due to two important factors. The endotoxin-containing cell walls are intrinsically noxious. Second, since many different enteric bacteria are found, the question of practicality of vaccine development encompasses not only problems involved in preparation of tens if not hundreds of different vaccines, but also the problem that with each vaccination with crude material one gives a large number of irrelevant antigens and one may well be concerned about antigenic competition (21) .
In Salmonella there has accumulated evidence that the qualitative constitution of the lipopolysaccharide (a component of the outer membrane containing the 0 antigen of the bacteria) is of importance for virulence (12, 13) . Killed vaccines of bacteria afford specific protection against infection by organisms of homologous 0-antigenic type but not against organisms of heterologous type (12, 13) . The structure of the polysaccharide part of the lipopolysaccharide with the 0-antigenic specificity has been stablished for several Salmonella species (6) . If key 0-antigenic determinants, without endotoxic activity, can be coupled to immunogenic carriers, it might be possible to give protection from infection by many organisms for which no effective prophylaxis is now available. Previous investigations have shown that individual dideoxyhexoses of Salmonella were haptenes which functioned as antigenic determinants when coupled to bovine serum albumin (BSA) or egg albumin and injected into goats and rabbits (18, 19) . The potential use of these synthetic antigens for eliciting protection was not studied.
The disaccharide methyl-3-0-a-tyvelopyranosyl-a-D-mannopyranoside, representative of the 0 antigen 9 determinant in Salmonella typhi, was recently synthesized (2) and found to be 10-fold more active than the methyl-a-D-tyveloside derivative in a precipitation-inhibition assay (unpublished data). This communication described the use of the synthetic disaccharide, covalently linked to BSA as a carrier, for immunization of mice. The mice formed antibody which was effective in a bactericidal assay in vitro against the 09 determinant. A sensitive in vivo test demonstrated that in immunized animals, after challenge with two strains of equal virulence but with different 0 antigens, the growth of the strain with the 09 determinant was suppressed in comparison with that with an 04 determinant. 
RESULTS
The only difference in 0-antigenic structure between a Salmonella strain with 09,12 specificity (like S. typhi) and one with 04,12 specificity (like S. typhimurium) is the substitution of one dideoxyhexose, tyvelose (09 specificity), for another, abequose (04 specificity) (Fig. 1) PL5 (09, 12) when the PL8/PL5 ratio was > 10.0: 1. In mice immunized with 25 ,ug of the synthetic antigen, the mean ratio was 13.2: 1, and the mean bacterial counts were 2.5 x 106 bacteria/g for PL8 and 1.9 x 105/g for PL5. Five of the seven mice in this group had ratios > 10.0: 1; for three of them the ratios were > 100:1. In the group given 5 4g of the synthetic antigen, three out of five mice were deemed to have suppression of growth of PL5; the mean bacterial counts were 3.7 x 106 and 5.6 x 105 bacteria/g for PL8 and PL5, respectively. None of the mice given 1.0,ug intraperitoneally in Freund complete adjuvant or 1.0 ,ug intravenously (without adjuvant) showed suppression of growth of PL5 as judged by the criteria used. Ten of the 15 mice given heat-killed bacteria showed suppression of PL5 growth (ratios of 36:1 to > 100: 1). The liver and spleen counts in the remaining five mice yielded ratios between 2.2:1 and 8.0:1, and the mice were deemed as having no significant suppression of PL5 growth. The mean bacterial counts were 2.6 x 105 and 104 bacteria/g for PL8 and PL5, respectively.
DISCUSSION
We have shown that the synthetic disaccharide tyvelosyl 1 t 3 mannose coupled to BSA elicited a specific humoral antibody response in mice. With the sensitive bactericidal antibody assay, a titer was detected as early as 7 days after initial immunization. A maximal titer of 10,240 was found 17 days after the last of four injections of 25 ,ug of the synthetic antigen in Freund complete adjuvant given 7 days apart. The bactericidal titer attained after immunization with heat-killed bacteria having the 09 antigenic determinant was higher, 40,960 (Table 1). The synthetic antigen elicited only a low hemagglutinating titer of 20, as compared with a titer of 640 elicited by immunization with the heat-killed bacteria. When the synthetic antigen was used as an immunogen in rabbits, specific antibody production was also detected: bacterial agglutination and the enzyme-linked immunosorbent assay showed specific 09 antibody response in immunized animals (unpublished data). To our knowledge this is the first demonstration that the antibody elicited by immunization with a disaccharide as a hapten covalently linked to a protein carrier displays specific bactericidal activity.
The principal advance in this work, however, is the demonstration that the synthetic antigen used as an immunogen in mice gives rise in vivo to suppression of growth of the bacterium with the 09 antigenic determinant relative to the growth of the bacteria with the 04 determinant ( Table 1 ). The mean ratio for 04/09 bacteria shifted from 0.8: 1 to 13.2: 1 in mice immunized with 25 gg of the antigen in adjuvant as compared with the group given 25 ,g of BSA in adjuvant only. The corresponding mean ratio in nonimmunized mice was 2.6: 1. The mean ratio in mice given heat-killed bacteria was >50: 1. Suppression of the bacteria with the 09 determinant, judged both as ratio and number of bacteria per gram of liver and spleen homogenate, was thus more effective when heat-killed bacteria were used for immunization as compared with the synthetic antigen. Two facts may account for this. First, immunization with heat-killed bacteria may elicit the formation of bactericidal antibodies directed against other antigens than the 09 determinant; and second, there was only an average of 4 mol of disaccharide per mol of BSA, and 4 is a small number. Theoretically, 57 mol of the disaccharide can be linked per mol of BSA (9) . The degree of heterogeneity of coupling is unknown. The possibility that we have been immunizing with a mixture of heavily substituted and perhaps unsubstituted BSA is not excluded. Double-diffusion studies with haptenated and unhaptenated BSA and anti-BSA formed in rabbits showed no evidence of antigenic modification of the BSA.
The suppression in mice immunized with the synthetic antigen roughly correlates with the occurrence of a bactericidal antibody response (Table 1) . We do not assert, however, that the suppression in vivo is mediated by the bactericidal antibody. Mouse complement does not bring about bacteriolysis (14) . Even if it has been suggested that humoral antibodies against cell-wall components play a role in the resistance to Salmonella infections (4, 16) , there is mounting evidence that effective resistance is primarily due to cell-mediated immunity (1, 3, 7, 17) . Cell-mediated immunity is difficult to demonstrate in the mouse. We have some evidence that guinea pigs immunized with the synthetic disaccharide coupled to BSA in complete Freund adjuvant and challenged with the appropriate lipopolysaccharide express typical delayed skin reactions.
The injections with Freund adjuvant intraperitoneally created a chronic inflammatory response with varying degrees of disruption of the normal peritoneal cavity. Peritoneal adhesions to the viscera were evident in many animals. We chose to delay challenge and sacrifice to about 4 weeks after the last immunizing injection to minimize the effect of the more acute responses. These 
